Hans Raskov

3.1k total citations · 1 hit paper
32 papers, 2.0k citations indexed

About

Hans Raskov is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Hans Raskov has authored 32 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 15 papers in Molecular Biology and 7 papers in Immunology. Recurrent topics in Hans Raskov's work include Gut microbiota and health (8 papers), Colorectal Cancer Screening and Detection (6 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Hans Raskov is often cited by papers focused on Gut microbiota and health (8 papers), Colorectal Cancer Screening and Detection (6 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Hans Raskov collaborates with scholars based in Denmark, Serbia and Germany. Hans Raskov's co-authors include Ismail Gögenür, Adile Orhan, Jan Pravsgaard Christensen, Hans‐Christian Pommergaard, Jakob Burcharth, Jacob Rosenberg, Steen Gammeltoft, Jesper Olsen, Jakob Albrethsen and Rasmus Peuliche Vogelsang and has published in prestigious journals such as Gastroenterology, Annals of Surgery and British Journal of Cancer.

In The Last Decade

Hans Raskov

32 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cytotoxic CD8+ T cells in cancer and cancer immunotherapy

2020 1.0k citations Hans Raskov, Adile Orhan et al. British Journal of Cancer profile →

Peers

Hans Raskov

ONCOL

IMMUN

MB

PRM

CR

Yao Yao China

Kiyoshi Yoshimura Japan

Yongsheng Wang China

Sofia Edin Sweden

Johannes Lemke Germany

Amir Baghbanzadeh Iran

Chiara Camisaschi Italy

Chanitra Thuwajit Thailand

Angélique Chevriaux France

Chunxiao Li China

Yao Yao China

Hans Raskov

1.1k ×1.1

ONCOL

731 ×0.9

IMMUN

825 ×1.1

MB

182 ×0.6

PRM

227 ×0.8

CR

Citations per year, relative to Hans Raskov Hans Raskov (= 1×) peers Yao Yao

Countries citing papers authored by Hans Raskov

Since Specialization

Citations

This map shows the geographic impact of Hans Raskov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans Raskov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans Raskov more than expected).

Fields of papers citing papers by Hans Raskov

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans Raskov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans Raskov. The network helps show where Hans Raskov may publish in the future.

Co-authorship network of co-authors of Hans Raskov

This figure shows the co-authorship network connecting the top 25 collaborators of Hans Raskov. A scholar is included among the top collaborators of Hans Raskov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans Raskov. Hans Raskov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Kvich, Lasse, Blaine Gabriel Fritz, Henrike Zschach, et al.. (2024). Biofilms and core pathogens shape the tumor microenvironment and immune phenotype in colorectal cancer. Gut Microbes. 16(1). 2350156–2350156. 15 indexed citations

2.

Raskov, Hans, Adile Orhan, Mette Ø. Agerbæk, & Ismail Gögenür. (2024). The impact of platelets on the metastatic potential of tumour cells. Heliyon. 10(14). e34361–e34361. 4 indexed citations

3.

Orhan, Adile, et al.. (2024). Introducing Neoadjuvant Immunotherapy for Colorectal Cancer. Annals of Surgery. 281(1). 95–104. 3 indexed citations

4.

Gögenur, Mikail, Mustafa Bulut, Anne‐Marie Kanstrup Fiehn, et al.. (2023). Neoadjuvant intratumoral influenza vaccine treatment in patients with proficient mismatch repair colorectal cancer leads to increased tumor infiltration of CD8+ T cells and upregulation of PD-L1: a phase 1/2 clinical trial. Journal for ImmunoTherapy of Cancer. 11(5). e006774–e006774. 13 indexed citations

5.

Raskov, Hans, et al.. (2023). Checkpoint inhibitor responses can be regulated by the gut microbiota – A systematic review. Neoplasia. 43. 100923–100923. 11 indexed citations

6.

Raskov, Hans, et al.. (2023). The Matrix Reloaded—The Role of the Extracellular Matrix in Cancer. Cancers. 15(7). 2057–2057. 8 indexed citations

7.

Bjarnsholt, Thomas, et al.. (2022). The gut microbiota can orchestrate the signaling pathways in colorectal cancer. Apmis. 130(3). 121–139. 23 indexed citations

8.

Raskov, Hans, et al.. (2022). Neutrophils and polymorphonuclear myeloid-derived suppressor cells: an emerging battleground in cancer therapy. Oncogenesis. 11(1). 22–22. 54 indexed citations

9.

Raskov, Hans, et al.. (2022). Metabolic switch in cancer – Survival of the fittest. European Journal of Cancer. 180. 30–51. 12 indexed citations

10.

Raskov, Hans, et al.. (2021). Natural Killer Cells in Cancer and Cancer Immunotherapy. Cancer Letters. 520. 233–242. 25 indexed citations

11.

Raskov, Hans, et al.. (2021). Cancer-Associated Fibroblasts and Tumor-Associated Macrophages in Cancer and Cancer Immunotherapy. Frontiers in Oncology. 11. 668731–668731. 94 indexed citations

12.

Raskov, Hans, Adile Orhan, Jan Pravsgaard Christensen, & Ismail Gögenür. (2020). Cytotoxic CD8+ T cells in cancer and cancer immunotherapy. British Journal of Cancer. 124(2). 359–367. 1035 indexed citations breakdown →

13.

Orhan, Adile, et al.. (2020). The prognostic value of tumour-infiltrating lymphocytes in pancreatic cancer: a systematic review and meta-analysis. European Journal of Cancer. 132. 71–84. 112 indexed citations

14.

Degett, Thea Helene, et al.. (2020). The impact of the gut microbiota on prognosis after surgery for colorectal cancer – a systematic review and meta‐analysis. Apmis. 128(2). 162–176. 22 indexed citations

15.

Watt, Sara Kehlet, Rasmus Peuliche Vogelsang, Florence Servant, et al.. (2020). Alterations in blood microbiota after colonic cancer surgery. BJS Open. 4(6). 1227–1237. 6 indexed citations

16.

Raskov, Hans, Jakob Burcharth, & Hans‐Christian Pommergaard. (2017). Linking Gut Microbiota to Colorectal Cancer. Journal of Cancer. 8(17). 3378–3395. 108 indexed citations

17.

Pommergaard, Hans‐Christian, Jakob Burcharth, Jacob Rosenberg, & Hans Raskov. (2015). Aspirin, Calcitriol, and Calcium Do Not Prevent Adenoma Recurrence in a Randomized Controlled Trial. Gastroenterology. 150(1). 114–122.e4. 55 indexed citations

18.

Pommergaard, Hans‐Christian, Jakob Burcharth, Jacob Rosenberg, & Hans Raskov. (2015). Advanced age is a risk factor for proximal adenoma recurrence following colonoscopy and polypectomy. British journal of surgery. 103(2). e100–e105. 13 indexed citations

19.

Pommergaard, Hans‐Christian, Jakob Burcharth, Jacob Rosenberg, & Hans Raskov. (2013). Topical Treatment with Diclofenac, Calcipotriol (Vitamin-D3 Analog) and Difluoromethylornithine (DFMO) Does Not Prevent Nonmelanoma Skin Cancer in Mice. Cancer Investigation. 31(2). 92–96. 3 indexed citations

20.

Albrethsen, Jakob, et al.. (2005). Upregulated expression of human neutrophil peptides 1, 2 and 3 (HNP 1-3) in colon cancer serum and tumours: a biomarker study. BMC Cancer. 5(1). 8–8. 129 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact